obviousness Archives - Page 2 of 9

In Ex parte Jung (Appeal No. 2021-003163), the examiner rejected the claims as obvious based on an inherency rationale. The PTAB reversed.

Independent claim 16 recited an inkjet set consisting of:

a black inkjet ink, a cyan inkjet ink, and two inkjet inks A and B… wherein

the inkjet ink A has a hue angle H* between 70 and 85 and a chroma C* between 30 and 80;

the inkjet ink B has a hue angle H* between 20 and 40 and a chroma C* between 30 and 80 …

The dispositive issue on appeal was whether the hue angle H* and chroma C* were inherent in the applied art.

The examiner cited a reference broadly disclosing mixtures of pigments, and including the specific pigments C.I. Pigment Orange 71, C.I. Pigment Yellow 139, C.I. Pigment Red 254, and C.I. Pigment Red 122 among a long list of suitable pigments. The examiner noted that these specific pigments were recited in the applicant’s dependent claims 19 and 21. Based on this, the examiner took the position that if these specific pigments were selected in the reference, the resulting inks “would intrinsically [i.e., inherently] have” the claimed H* and C* values.

The applicant argued that even if the specific pigments were selected in the reference, the claimed H* and C* values would not necessarily result. The applicant stated that these limitations “are not only achieved by selecting specific pigments, but also by the amounts of the pigments used and the weight ratio of the different pigments in the mixture.” Additionally, the applicant provided calculations of H* and C* values resulting from the examples of the reference, showing them to fall outside the claimed ranges. However, the examiner dismissed these calculations as “attorney argument and not evidence.”

The PTAB sided with the applicant. The PTAB found that “the use of the recited pigments alone is not adequate to guarantee that the H* and C* limitations are met” and that the ratio of different pigments mattered. Regarding the calculations provided by the applicant, the PTAB found that the examiner dismissed them in error (“There is no dispute that the calculations are based on examples disclosed by [the reference], and there is no dispute as to the accuracy of the calculations. Because [the reference] itself is evidence, the calculations made using the data from [its] examples should not have been disregarded as mere ‘attorney arguments.’”).

The PTAB acknowledged that the claims still might have been obvious if the reference “teaches or suggests combining pigments in a way (e.g., optimizing the weight ratios of different pigments) that would have resulted in H* and C* values within the scope of claim 16.” However, the PTAB found no such teaching or suggestion. While the reference taught that the pigments or mixture of pigments be present “in an amount of 0.1 to 20% by weight based on the total weight of the non-aqueous inkjet ink,” the reference provided no teaching or suggestion for weight ratios among different pigments. Accordingly, the PTAB reversed the obviousness rejection.

Takeaway: Whenever an examiner takes the position that a claimed property is inherent in the applied art, it is important to carefully evaluate embodiments of the applied art that might result in the claimed property. Inherency requires necessity, not merely possibility. That is, just because it might be possible for the applied art to satisfy a claimed property, that does not mean that the applied art necessarily satisfies the property. If the prior art does not necessarily satisfy the claimed property, then inherency has not been established.

Judges: Abraham, Kennedy, Gupta

On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Ex parte Chen (Appeal 2021-001752) affirming an Examiner’s rejection of claims directed to a polyisocyanurate foam composition comprising a certain two-component blowing agent.

In making the rejection, the Examiner used the same technique used in Almirall, LLC v. Amneal Pharm., No. 2020-2331 (Fed. Cir. Mar. 14, 2022) (discussed here) – she applied a primary reference disclosing one of the claimed blowing agent components and combined it with a secondary reference disclosing an expansive laundry list of blowing agent components that partially overlapped with species described in the primary reference and which, importantly, included the claimed blowing agent component missing from the primary reference. In justifying the combination, the Examiner took the position that because all the blowing agent components in the laundry list were “interchangeable and equivalent” it would have been obvious to substitute one of the overlapping components in the primary reference with the missing component.

Applicant traversed the rejection in three different ways in their Brief. First, they argued that neither reference, on its own, rendered the claims obvious (never a good idea in an obviousness rejection based on two references). Next, they asserted that because the primary and secondary references focused on different types of blowing agents one of ordinary skill in the art would not have combined the references. And finally, they argued that the data submitted during prosecution showed unexpected synergy for their blowing agent composition at their claimed ratios.

The Board, in its decision affirming the Examiner, ignored the first argument, rejected the second argument as lacking evidence and support, and found the data submitted during prosecution to be insufficient because it did not show the beneficial trend asserted and was not commensurate in scope with the claims.

Takeaway: Unfortunately, and as we learned in our prior blog on Almirall, where Applicant went wrong in this case was in not fleshing out its non-combinability argument. The primary and secondary references did indeed focus on different types of blowing agents – saturated v. unsaturated. A declaration explaining why the co-blowing agents listed in each reference were specially tailored for use with only one of these types of agents, and an explanation why only the few overlapping agents could be used with both types, might well have overcome the rejection.

Judges: J. Robertson, M. Cashion, Jr., S. McGee

Conclusions of obviousness require a reasonable expectation of successfully making and using an applicant’s claimed invention. Ex parte Micka (Appeal 2021-003755) is a recent decision from the Patent Trial and Appeal Board (“Board”) that shows whether there is a reasonable expectation of success can depend on the number of selections required to arrive at a claimed invention and how those selections would have been expected to affect the resulting combination of elements/ingredients.

The claims in Micka were directed to a process of preparing a solid dosage form by blending an active pharmaceutical ingredient (API) with a natural gum and a particular combination of hydrophilic gelling polymers, “wherein the solid dosage form deters abuse and provides immediate release of the at least one API.”

The Examiner relied on a prior art reference for the specific ingredients and alleged that it would have been obvious to combine them in the manner claimed because the reference describes blending the ingredients and the dosage form as providing immediate release and being abuse resistant. This, however, was not the complete picture.

First, the appellant pointed out that the prior art described hundreds of polymers, diluents, binders, lubricants, disintegrants, gelling agents, plasticizers, and release modifiers at any concentration from 0-95% w/w in the abuse deterrent compositions. According to the appellant’s estimate, which the Examiner did not contest, the prior art disclosed ~17 trillion possible combinations of polymers, diluents, binders, lubricants, disintegrants, gelling agents, plasticizers, and release modifiers before even considering the concentrations.

Second, the appellant pointed out that the prior art’s focus was on controlled release compositions. The appellant’s argument here was not as strong because the prior art reference did use the phrase “immediate release,” but only once in the abstract. The Examiner grabbed onto this single mention of “immediate release” to argue there would have been a motivation and a reasonable expectation of success. The Board did not agree.

The Examiner’s error here resided in the fact that the prior art reference did not differentiate between excipients that would result in controlled release and immediate release. In the Examiner’s view, this was irrelevant because the same ingredients were suitable for making both. Not only did the Board disagree with this finding, but the Board also found that the prior art taught the choice of ingredients affects the release such that “it cannot be the case that any and all of these possible combinations will provide immediate release dosage forms.” Having no guide for what ingredient(s) could provide an immediate release composition, the Board found there was no reasonable expectation of success and reversed the rejection.

Takeaway: The factual scenarios under which the lack of a reasonable expectation of success can be successfully argued are less common than motivation to combine. A key in Micka was the claimed composition providing the immediate release of the API. And the facts in Micka were particularly strong because of the litany of selections required to arrive at the claimed composition and the complete lack of guidance as to which selections would have resulted in the immediate release property. Without claiming the immediate release property, the obviousness determination would have devolved into whether it would have been obvious to select the combination of ingredients – a more difficult position to rebut.

Judges: J. Morgan, J. Schneider, M. Valek

In Ex parte Stone (Appeal 2021-004177), the Patent Trial and Appeal Board (“Board”) reversed the Examiner’s obviousness rejection citing Lucas, Kaersgaard, and Wu because the Examiner did not meet his initial burden of presenting a prima facie case of obviousness.

Appellant’s claimed invention in Stone was directed to a method of “selectively removing a proteinaceous impurity from a sample comprising at least an immunoglobulin and the proteinaceous impurity.” It included steps of “adjusting the solution pH of the sample, such that the pH is within 2.0 pH units of the isoelectric point of the proteinaceous impurity to be selectively removed,” then “contacting the sample with activated carbon, [which] selectively binds the proteinaceous impurity,” and “removing the activated carbon from the sample.”

Lucas described the presence of contaminants in monoclonal antibodies and also taught that the contaminants should be removed to produce monoclonal antibodies of the highest purity. However, Lucas did not disclose how to remove the contaminants. The Examiner acknowledged this deficiency. The Examiner found that Kaersgaard described removing PEG from immunoglobulins using activated carbon and Wu described removing proteinaceous material from corn syrup using activated carbon. The Examiner also found that Wu disclosed that the maximum adsorption of the proteinaceous material by the activated carbon occurred at the protein’s isoelectric point. The Examiner thus determined that it would have been obvious to a skilled artisan “to remove the impurities of Lucas” by Wu’s method “motivated by the desire for highest purity, described by Lucas;” and reasoned that because Kaersgaard “teach[es] using very similar methods for purifying immunoglobulins, and explicitly discuss[es] using the methods to remove other impurities, an artisan in this field would attempt this process with a reasonable expectation of success.”

Appellant argued that the combination of cited references did not suggest the claimed method or provide the motivation to combine Wu with Lucas and Kaersgaard. Specifically, Appellant argued that none of the cited references described the selective removal of a protein impurity from other proteins, noting that Kaersgaard disclosed removing PEG rather than a protein impurity from immunoglobulins and Wu disclosed removing proteins from corn syrup, but did not teach selectively removing a proteinaceous impurity from other proteins based on the isoelectric point of the impurity as required by Appellant’s claimed method.

The Board agreed with the Appellant. The Board noted that Lucas identified the need to remove protein contaminants but did not teach how to do so. The Board also noted that neither Kaersgaard nor Wu described selective removal of a protein. In particular, Wu described removal of all protein contaminants, despite teaching that the maximum adsorption of a protein could be achieved using the pH of the protein’s isoelectric point. The Board noted that the Examiner did not provide adequate reasoning to modify Wu to selectively remove impurities. Specifically, regarding the Examiner’s contention that Appellant’s arguments “assume that a person of skill in the art cannot make the leap from the explicit experiments and motivations of the reference to other, closely related applications and goals,” the Board pointed out that the Examiner did not provide a reason for making the “leap” from adsorbing all proteins from a solution to adsorbing only certain proteins based on their isoelectric point.

The Board emphasized that it was the Examiner who had the initial burden of presenting a prima facie case of obviousness and that ordinary creativity and/or common sense “cannot be used as a wholesale substitute for reasoned analysis and evidentiary support, especially when dealing with a limitation missing from the prior art references specified.” The Board cautioned that although the Supreme Court emphasized “an expansive and flexible approach” to the obviousness approach, it also reaffirmed the importance of determining “whether there was an apparent reason to combine the known elements in the fashion claimed by the patent at issue.”

Because the Examiner failed to provide sufficient reason to selectively remove proteinaceous impurity as claimed, the Board reversed the Examiner’s obviousness rejection.

Takeaway: Obviousness can be established by combining or modifying the teachings of prior art references to produce a claimed invention where there is some teaching, suggestion, or motivation to do so and there is a reasonable expectation of success. The Examiner in Stone did not establish obviousness because, although Wu disclosed adsorption of a protein was related to the pH of the protein’s isoelectric point, the Examiner failed to present sufficient reasoning to modify Wu’s teachings to achieve the claimed selective removal of a proteinaceous impurity. As the Board pointed out, an examiner’s assertion of ordinary creativity and/or common sense cannot substitute for reasoned analysis and evidentiary support.

Judges: E. B. Grimes, R. M. Lebovitz, and G. C. Best

Composition claims sometimes recite a ratio of amounts of two different components in the composition. Similarly, claims relating to a polymeric compound sometimes recite a ratio between two different structural units of the compound. In evaluating obviousness, U.S. examiners search the prior art for ratios that overlap the claimed ratio. Ex parte Kraus (Appeal No. 2021-002347) is a recent decision of the Patent Trial and Appeal Board (“Board”) in which the examiner went a little too far in trying to find such a ratio in the prior art.

Independent claim 1 related to a polycondensate comprising at least four different structural units: (I), (IIa), (IIb) and (III). Among other limitations, the claim recited a molar ratio of structural unit (IIa) to (IIb) within the range of 0.2 to 1.5.

The examiner rejected claim 1 as obvious over one reference (Wieland), and separately over a different reference (Kraus). In the rejection based on Wieland, the examiner relied on a ratio that included structural units corresponding to (IIa) and (IIb). However, the examiner acknowledged that this was not exactly a ratio of (IIa) to (IIb) since the structural units of Wieland corresponding to (IIa) and (IIb) both were encompassed by the denominator of Wieland’s disclosed ratio. The examiner also relied on values derived from two specific examples in Wieland to construct a ratio of (IIa) to (IIb) overlapping the claimed range.

The Board reversed the rejection over Wieland. The Board found that “[t]he Examiner has not explained sufficiently why one of ordinary skill in the art would mix and match molar concentration values from two different examples to determine a ratio of (IIa) to (IIb) as claimed, particularly given that Wieland’s ratio is different.” The examiner’s calculation “involves picking and choosing convenient values from two unrelated examples to calculate a ratio not used by Wieland.”

In the rejection based on Kraus, the examiner combined a disclosed ratio of structural unit (I) to (IIa) with a disclosed ratio of the sum of structural units (I) and (IIa) to structural unit (IIb). The examiner found that this combination supported a range of molar ratios (IIa) to (IIb) that overlapped the claimed range of 0.2 to 1.5.

The Board also reversed this rejection. The Board found that the examiner had not adequately explained how the two disclosed ratios could be combined to obtain the claimed ratio. The Board noted that “[t]he calculation posited by the Examiner apparently requires substitution of a range within another range,” which it found not to be obvious.

Takeaway: A ratio between two components in a composition, or two structural units in a polymeric compound, can be a useful way to distinguish a claimed invention from prior art. If an examiner appears to be stretching the prior art to construct an overlapping ratio, it is worth challenging the examiner’s rationale.

Judges: Hastings, Kennedy, Cashion Jr.

Last month, in Almirall, LLC v. Amneal Pharm., No. 2020-2331 (Fed. Cir. Mar. 14, 2022) the Federal Circuit affirmed the Board’s holding of obviousness in an inter partes review. In Almirall the main issue in the case was the absence, in the primary reference, of the claimed gelling agent.

Petitioner, in asserting obviousness, used a secondary reference that disclosed both the claimed gelling agent and the gelling agent of the primary reference in a “laundry list” of ten broad types, or classes, of gelling agent useful in the secondary reference. Importantly, Petitioner also included substantial expert testimony characterizing the claimed gelling agent and the gelling agent of the primary reference as being “closely related,” as capable of being “interchangeably used” in the claimed formulations “in the same concentration range,” that such a substitution was “routine and predictable,” and that one of ordinary skill in the art “would not have expected any incompatibilities.”

Patentee, unable to successfully counter this mountain of evidence, was left to argue at the margins, and focused on the non-overlapping concentration ranges of gelling agents used in the primary and secondary references. However, the Court was having none of it:

Ultimately, despite Almirall’s attempts to argue otherwise, this case does not depend on overlapping ranges. It is simply a case of substituting one known gelling agent for another. Each may be effective at a different concentration in different formulations, but that is just a property of the particular known material, subject to conventional experimentation.

Takeaway: The Almirall case is interesting because the initial “hook” that led to the finding of obviousness was one that Examiners use in rejecting claims all the time: a secondary reference with an expansive laundry list of agents that includes both the claimed agent and the agent of the primary reference. The difference between the inter partes review in Almirall and regular prosecution, however, is that during prosecution the Examiner simply alleges interchangeability based on the common listing, without more, while in Almirall Petitioner submitted substantial evidence regarding combinability, interchangeability, and expectation of success. The Almirall case thus provides applicants with a good example of the type of evidence, albeit in the reverse, to submit in traversing such rejections during prosecution.

Judges: Lourie, Chen, Cunningham

Functional equivalence is a rationale that examiners often rely on in support of an obviousness rejection. However, as discussed in one of our previous blogs, examiners may misapply the rationale by ignoring the different function or purpose of an allegedly equivalent component disclosed in prior art. A recent decision of the Patent Trial and Appeal Board (“Board”) – Ex parte Takasu (Appeal 2021-001290) – is another illustrative case.

Appellant’s claimed invention in Takasu was a substrate of a single crystal of formula RAMO₄, where, among other things, R could be Sc, A could be Al, and M could be Mg. The claimed RAMO₄ substrate had an epitaxially-grown surface and a satin-finish surface, each having specific surface roughness.

Yoshii, the primary reference relied on by the Examiner, provided a sapphire substrate for epitaxial growth that could be easily polished. The Examiner found that Yoshii as evidenced by Hansen disclosed a sapphire single crystal substrate that allegedly had the claimed roughness on its front and back sides. The Examiner admitted that the sapphire substrate disclosed in Yoshii was not a RAMO₄ substrate. However, the Examiner found a secondary reference, Yoshida, which disclosed ScAlMgO₄ as one of the material options for a single crystalline substrate as a functional equivalent to sapphire for epitaxial growth. The Examiner thus concluded Appellant’s claimed RAMO₄ substrate would have been obvious over Yoshii in view of Yoshida as evidence by Hansen.

Appellant argued that a sapphire substrate and a RAMO₄ substrate were not equivalent to each other in terms of surface polishing properties.

The Board agreed with Appellant and emphasized that, as stated by the Examiner herself, Yoshida merely disclosed ScAlMgO₄ as “a functional equivalent to sapphire for epitaxial growth, but … not for surface polishing properties.”

Because a sapphire substrate is not functionally equivalent to a RAMO₄ substrate in terms of surface polishing properties, the Board found that the Examiner’s reliance upon Yoshida was misplaced and reversed the obviousness rejection.

Takeaway: As cautioned in MPEP § 2144.06 II, the equivalency of a proper substituting equivalent must be recognized in the prior art for the same purpose and cannot be based on applicant’s disclosure or the mere fact that the components at issue are functional or mechanical equivalents. Thus, arguments rebutting an examiner’s obviousness rejection relying on functional equivalence may be successfully advanced by carefully analyzing the function and purpose of substituted and substituting components disclosed in prior art.

Judges: J. T. Smith, B. A. Franklin, and J. R. Snay

Ex parte Nakanishi, is a recent decision of the Patent Trial and Appeal Board (PTAB) addressing obviousness of a claim directed to a steel composition.

The claim at issue recited, in part:

A non-oriented electrical steel sheet having a chemical composition consisting of, in mass%…

Si: 1.0% or more and 4.0% or less;

Mn: 0.10% or more and 3.0% or less…

Al: less than 0.0005%;

Cu: 0.02% or more and less than 0.04%; and

Ca: 0.003% or more and 0.0100% or less…

In asserting obviousness, the examiner cited a single prior art reference disclosing a steel sheet including components and amounts that could overlap with those recited in the claim. Applicant’s arguments focused first on differences between the claimed composition and the prior art composition and then on evidence of unexpected results.

Applicant’s arguments as to composition focused particularly on the amounts of Al, Cu, and Ca in the claims and the prior art reference. Notably, applicant’s ranges of amounts of Al, Cu, and Ca were much narrower than those in the prior art reference.

Component	Claim	Prior Art Reference
Al	Al < 0.0005%	Al ≤ 3%
Cu	0.02% ≤ Cu < 0.04%	Cu ≤ 5%
Ca	0.003% ≤ Ca ≤ 0.0100%	(total content of Mo, W, Sn, Sb, Mg, Ca, Ce, and Co trace elements) ≤ 0.5%

Applicant first argued that the prior art reference did not disclose a single example composition having the claimed amounts of Al, Cu, and Ca. The PTAB quickly dismissed this argument, noting that the prior art reference was “not limited to its examples.”

Next applicant argued that the prior art reference did not recognize that the amounts of Al, Cu, and Ca were result effective and undue experimentation would have been required to arrive at the claimed narrow ranges. The PTAB replied that the prior art reference would have suggested to a skilled artisan that “all Al, Cu, and total trace element amounts within the disclosed ranges are effective for achieving” the goal of the prior art reference, “a non-oriented magnetic steel sheet whose core loss in a high frequency range can be fully reduced… including amounts within the… [claimed] ranges.”

Applicant then turned to its experimental results. Applicant argued that its experimental results showed that adding Ca in the claimed amounts to a steel sheet containing ultra-low amounts of Al unexpectedly reduces iron loss.

The PTAB noted that applicant’s experimental results were limited to compositions having a Si content of 1.3% and 1.6 % and an Mn content of 0.5%, while the claim encompassed Si contents as high as 4.0% and Mn contents as high as 3.0%. The PTAB then noted a statement in applicant’s specification that Si and Mn have the effect of reducing iron loss (the same effect applicant attributed to addition of Ca in describing its experimental results). In view of this statement, the PTAB concluded that applicant would have to provide evidence that its experimental results were representative of compositions including the minimum claimed amount of Ca and the maximum claimed amounts of Si and Mn, to effectively rebut the examiner’s assertion of obviousness.

Takeaway: Once an examiner has established that a prior art range overlaps with a claimed range, it will be difficult to persuade the examiner (or PTAB) that selection of a subrange would not have been obvious in the absence of evidence of unexpected results – in this case, the PTAB seemed annoyed that applicant even tried. It may be preferable to leave out arguments that will never succeed (e.g., the claimed composition is not exemplified in the prior art reference) and emphasize the results that might succeed (unexpected results).

A composition claim with many components, each with its own range of amounts, can make it difficult to prove that evidence of unexpected results is “commensurate in scope” with the claim. In this case, applicant showed a desirable effect over the entire range of amounts of the component it believed was important (Ca amount), provided a limited number of data points for the other components. It is often not practical to prepare a large number of compositions encompassed by a claim, but this can be addressed with a technical explanation for why additional experiments would not be expected to yield significantly different results (even more helpful if such explanation is provided in a declaration by a skilled artisan).

Judges: Owens, McGee, Inglese

Obviousness rejections of composition claims are often premised on an examiner’s assertion that it would have been obvious to replace a component in a primary reference composition with a functionally equivalent component from a secondary reference. As discussed in a prior blog, the context of a disclosure of functional equivalence is key because obviousness requires an examiner to show a skilled artisan would have had an apparent reason to modify the prior art to arrive at the claimed invention. And when a component is taught to be an alternative for a completely different purpose, this undercuts the apparent reason to modify the prior art. Ex parte Shooshtari is illustrative.

The claims on appeal in Shooshtari were drawn to a binder composition that included “a catalyst for catalyzing a crosslinking reaction between the reducing sugar and the crosslinking agent, wherein the catalyst comprises a sulfonic acid compound.” The primary reference relied on by the Examiner disclosed a binder composition that included a pH adjuster, such as HCl, for preventing unwanted polymerization, but it did not disclose the presence of a sulfonic acid compound.

To remedy this deficiency the Examiner relied on a secondary reference that taught a binder composition containing a mineral acid catalyst, such as HCl or p-toluene sulfonic acid, to effect crosslinking reactions. According to the Examiner, it would have been obvious to replace the HCl pH adjuster of the primary reference with the sulfonic acid polymerization catalyst of the secondary reference. The Board disagreed.

In particular, the Board found that the primary reference taught HCl for the sole purpose of adjusting the pH to inhibit unwanted polymerization, while the secondary reference taught HCl and sulfonic acid as acid catalysts to effect crosslinking reactions–a completely different purpose. Consequently, the Board held the Examiner failed to identify a reason why a skilled artisan would have sought to include the acid catalyst of the secondary reference in the composition of the primary reference.

Takeaway: Shooshtari shows the value in analyzing the purpose of each component of a composition when facing an obviousness rejection that relies on functional equivalence. The purpose and function of the components ties into whether there is an apparent reason to modify the prior art in the manner proposed by the Examiner. Here, the purpose of the components in each of the references was contradictory to the other such that a skilled artisan would not have had a reason to equate and replace them. Accordingly, when facing a rejection that relies on functional equivalence it is important to fully assess the purpose and function of the components involved.

Judges: T. Ownes, W. Wilson, J. Snay

There is no requirement to provide unexpected results until the Patent Office establishes a prima facie case of obviousness. Seems simple, but Ex parte Popplewell shows Examiners still put the cart before the horse and improperly seek evidence of unexpected results.

This initial burden for showing unpatentability falls on the patent office because § 102 mandates that “[a] person shall be entitled to a patent unless.” See In re Glaug, 283 F.3d 1335, 1338 (Fed. Cir. 2002) (the PTO “bears the initial burden of presenting a prima facie case of unpatentability… However, when a prima facie case is made, the burden shifts to the applicant to come forward with evidence and/or argument supporting patentability.”). Despite this unambiguous framework of burden shifting, Examiners routinely seek evidence of unexpected results prematurely.

In Popplewell, the independent claim required a spray dryer in a particular method to have inlet and outlet air humidity values between 0–4 and 10–20 g H₂O/kg dry air, respectively. The Examiner admitted that the prior art relied on did not teach the inlet or outlet air humidity. While this should have been the end of examination, the Examiner took the position that the claimed inlet and outlet air humidities did not provide an unexpected result over the prior art.

On appeal, the Board found the Examiner’s statement regarding the claimed air humidities to be nothing more than a “mere conclusory statement[]” lacking an “articulated reasoning with some rational underpinning to support the legal conclusion of obviousness.” From the Board’s perspective, the Examiner failed to show that the prior art taught or suggested the inlet and outlet air humidities and failed to provide any explanation as to why the claimed humidities would have been obvious. Consequently, the Board held the Examiner’s request for a showing of unexpected results was inappropriate.

Takeaway: Poppelwell is a good reminder that: one, “obviousness requires a suggestion of all limitations in a claim”; and two, an Examiner’s demand for evidence of unexpected results prior to showing a suggestion of all limitations is improper. CFMT, Inc. v. Yieldup Intern. Corp., 349 F.3d 1333, 1342 (Fed. Cir. 2003). It is surprising to see a case like this on appeal because it requires the Examiner and an appeal brief review panel to misunderstand the burden shifting framework before the case is sent to the Board, but it shows why some appeals are inevitable.

Judges: G. Best, L. Ren, M. Cashion

Newer Posts

Older Posts

Effective Showing of Non-Inherency

Effective Showing of Non-Inherency

Oh, and about that Laundry List…

PTAB: Too Many Unguided Selections Required for Reasonable Expectation of Success

Obviousness Rejection Reversed Because Reason for Making “Leap” from Prior Art Not Provided

PTAB Finds Claimed Ratio Not Obvious

Inclusion in “Laundry List” Supportive of Interchangeability

Functional Equivalence Misapplied, Again!

Cut to the Chase – When Claimed Ranges and Prior Art Ranges Overlap, Focus on Unexpected Results

Functional Equivalence Requires Similar Purpose

PTAB Finds Examiner’s Request for Unexpected Results Inappropriate

USPTO Further Delays Non-DOCX Fee Until January 17, 2024

USPTO Further Delays Non-DOCX Fee Until June 30, 2023